UK Penny Stocks To Watch In October 2024

In This Article:

Over the last 7 days, the UK market has remained flat, though it is up 11% over the past year and earnings are forecast to grow by 14% annually. The term 'penny stocks' might feel like a relic of past market eras, but the potential they represent is as real as ever. Typically referring to smaller or relatively new companies, these stocks can provide a mix of affordability and growth potential when paired with strong financials.

Top 10 Penny Stocks In The United Kingdom

Name

Share Price

Market Cap

Financial Health Rating

Tristel (AIM:TSTL)

£3.95

£184.64M

★★★★★★

ME Group International (LSE:MEGP)

£2.115

£768.58M

★★★★★★

Next 15 Group (AIM:NFG)

£4.355

£407.27M

★★★★☆☆

Supreme (AIM:SUP)

£1.555

£180.75M

★★★★★★

FRP Advisory Group (AIM:FRP)

£1.325

£324.93M

★★★★★★

Stelrad Group (LSE:SRAD)

£1.50

£191.03M

★★★★★☆

Luceco (LSE:LUCE)

£1.596

£235.97M

★★★★★☆

Ultimate Products (LSE:ULTP)

£1.41

£119.17M

★★★★★★

Serabi Gold (AIM:SRB)

£0.86

£70.81M

★★★★★★

Integrated Diagnostics Holdings (LSE:IDHC)

$0.457

$261.6M

★★★★★★

Click here to see the full list of 466 stocks from our UK Penny Stocks screener.

Let's review some notable picks from our screened stocks.

Serabi Gold

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Serabi Gold plc is involved in the evaluation, exploration, and development of gold and other metals mining projects in Brazil, with a market cap of £70.81 million.

Operations: The company's revenue primarily comes from its gold mining and exploration activities, generating $75.85 million.

Market Cap: £70.81M

Serabi Gold plc has demonstrated substantial earnings growth, with a notable 462.3% increase over the past year, surpassing industry averages. The company's financial health appears robust, as short-term assets of $31.2 million exceed both short and long-term liabilities, while cash reserves surpass total debt. Recent production results show an increase in gold output to 9,489 ounces for Q3 2024, supporting their reiterated annual guidance of up to 40,000 ounces. Operational updates highlight advancements at the Coringa project and promising exploration results at Palito. However, Return on Equity remains modest at 11.5%, indicating potential areas for improvement in capital efficiency.

AIM:SRB Financial Position Analysis as at Oct 2024
AIM:SRB Financial Position Analysis as at Oct 2024

Tristel

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally with a market cap of £184.64 million.